9 METERS BIOPHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
9 Meters Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2022.
  • 9 Meters Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $737K, a 6.81% increase year-over-year.
  • 9 Meters Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $3.99M, a 48.6% increase year-over-year.
  • 9 Meters Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.94M, a 63.2% increase from 2021.
  • 9 Meters Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.41M, a 48.9% decline from 2020.
  • 9 Meters Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.72M, a 64.5% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $3.94M +$1.53M +63.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $2.41M -$2.31M -48.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $4.72M +$1.85M +64.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $2.87M -$934K -24.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
2018 $3.81M -$2.21M -36.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $6.02M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.